Wells Fargo & Company APOGEE THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
16,853
Previous 18,104 6.91%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-1,251 Reduced 6.91%
16,853 $0
Q1 2025

May 13, 2025
BUY
N/A
399 Added 2.25%
18,104 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-80,585 Reduced 81.99%
17,705 $0
Q3 2024

Nov 13, 2024
BUY
N/A
86,710 Added 748.79%
98,290 $0
Q2 2024

Aug 13, 2024
SELL
N/A
-1,848 Reduced 13.76%
11,580 $0
Q1 2024

May 10, 2024
BUY
N/A
7,570 Added 129.22%
13,428 $0
Q4 2023

Feb 09, 2024
BUY
N/A
1,455 Added 33.05%
5,858 $0
Q3 2023

Nov 13, 2023
BUY
N/A
4,403 New
4,403 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email